0.155
price down icon86.97%   -1.035
 
loading
Precedente Chiudi:
$1.19
Aprire:
$0.155
Volume 24 ore:
505
Relative Volume:
6.23
Capitalizzazione di mercato:
$N/A
Reddito:
$662.00K
Utile/perdita netta:
$-29.02M
Rapporto P/E:
-0.0182
EPS:
-8.5
Flusso di cassa netto:
$-12.54M
1 W Prestazione:
-86.97%
1M Prestazione:
-86.97%
6M Prestazione:
-86.97%
1 anno Prestazione:
-86.10%
Intervallo 1D:
Value
$0.155
$0.155
Intervallo di 1 settimana:
Value
$0.155
$0.155
Portata 52W:
Value
$0.155
$1.19

Orgenesis Inc Stock (ORGS) Company Profile

Name
Nome
Orgenesis Inc
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
0
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
ORGS's Discussions on Twitter

Confronta ORGS con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ORGS
Orgenesis Inc
0.155 0 662.00K -29.02M -12.54M -8.50
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
441.36 111.36B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
733.04 77.98B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ARGX
Argen X Se Adr
800.01 50.33B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
359.27 47.46B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ONC
Beone Medicines Ltd Adr
338.19 37.43B 4.98B 69.59M 525.67M 0.5197

Orgenesis Inc Stock (ORGS) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2018-12-20 Iniziato Dawson James Buy

Orgenesis Inc Borsa (ORGS) Ultime notizie

pulisher
Jan 08, 2026

Is Orgenesis Inc. (45O) stock a safe buy pre earnings2025 Earnings Surprises & Stock Timing and Entry Methods - Улправда

Jan 08, 2026
pulisher
Jan 03, 2026

Retail Trends: Is Orgenesis Inc 45O stock a safe buy pre earnings2025 Market WrapUp & AI Powered Buy/Sell Recommendations - moha.gov.vn

Jan 03, 2026
pulisher
Dec 31, 2025

Aug Gainers: Is Orgenesis Inc 45O stock a safe buy pre earningsInflation Watch & Verified Swing Trading Watchlists - Bộ Nội Vụ

Dec 31, 2025
pulisher
Dec 28, 2025

Top Companies Developing Cell Therapy Treatments For Diabetes in 2026 - BioInformant

Dec 28, 2025
pulisher
Dec 23, 2025

Published on: 2025-12-23 22:10:30 - earlytimes.in

Dec 23, 2025
pulisher
Dec 18, 2025

Regenerative Therapies Market Forecast Through 2032 - openPR.com

Dec 18, 2025
pulisher
Dec 18, 2025

Statera Biopharma (NASDAQ:STAB) vs. Orgenesis (NASDAQ:ORGS) Financial Contrast - Defense World

Dec 18, 2025
pulisher
Dec 16, 2025

Victor Miller Joins NorthStar Medical Radioisotopes, LLC as Chief Financial Officer - Business Wire

Dec 16, 2025
pulisher
Dec 12, 2025

Is Oriental Culture Holding LTD a good long term investmentUtilities Sector Analysis & Crush the Market with Breakout Winners - earlytimes.in

Dec 12, 2025
pulisher
Dec 10, 2025

Financial Contrast: Pharmaxis (OTCMKTS:PXSLY) and Orgenesis (NASDAQ:ORGS) - Defense World

Dec 10, 2025
pulisher
Dec 06, 2025

What analysts say about GoPro Inc stockResistance Zone Identification & Machine Learning Stock Picks, Daily - earlytimes.in

Dec 06, 2025
pulisher
Dec 05, 2025

How Orgenesis Inc. (45O) stock trades in high volatility2025 Market Outlook & Real-Time Buy Zone Alerts - Newser

Dec 05, 2025
pulisher
Dec 05, 2025

Is Orgenesis Inc. (45O) stock suitable for passive index fundsWeekly Gains Report & Precise Swing Trade Alerts - Newser

Dec 05, 2025
pulisher
Dec 04, 2025

Apex Tech Acquisition Inc files for IPO of up to $60 million - marketscreener.com

Dec 04, 2025
pulisher
Dec 04, 2025

Is Orgenesis Inc. (45O) stock protected from inflation2025 Retail Activity & Fast Exit Strategy with Risk Control - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Will Orgenesis Inc. (45O) stock split increase liquidityJuly 2025 Outlook & Long-Term Safe Investment Ideas - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

How Orgenesis Inc. (45O) stock compares with top peersShort Setup & Accurate Entry/Exit Alerts - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Why Orgenesis Inc. (45O) stock attracts HNW investorsJuly 2025 Final Week & Proven Capital Preservation Tips - Newser

Dec 04, 2025
pulisher
Dec 02, 2025

Will Orgenesis Inc. (45O) stock beat international competition2025 Market Trends & AI Forecasted Entry and Exit Points - Newser

Dec 02, 2025
pulisher
Nov 22, 2025

Orgenesis (NASDAQ:ORGS) Stock Price Up 257.1% – Here’s Why - Defense World

Nov 22, 2025
pulisher
Nov 20, 2025

Will Orgenesis Inc. (45O) stock gain from lower interest ratesProduct Launch & Verified Momentum Stock Alerts - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Is Orgenesis Inc. (45O) stock a buy during volatile marketsWeekly Trade Summary & Real-Time Sentiment Analysis - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Why institutional investors increase stakes in Orgenesis Inc. (45O) stockJuly 2025 Review & AI Enhanced Trade Execution Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Why Orgenesis Inc. (45O) stock is a strong analyst pick2025 Momentum Check & Real-Time Market Trend Scan - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Orgenesis Inc. (45O) stock included in top ETFsMarket Growth Report & Community Verified Trade Alerts - newser.com

Nov 19, 2025

Orgenesis Inc Azioni (ORGS) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$32.25
price down icon 4.73%
$106.21
price up icon 0.92%
$120.28
price down icon 2.43%
$109.00
price up icon 2.76%
$161.42
price up icon 1.35%
biotechnology ONC
$338.19
price down icon 0.03%
Capitalizzazione:     |  Volume (24 ore):